gerd and glp-1 GI Hepatology News GLP-1 Agonists In Obesity
Description
The lower rate of non-CV deaths was because of lower infectious deaths, in particular COVID-19related deaths, suggesting that semaglutide has a favorable outcome in terms of mortality across a broad population of patients with CV disease and obesity (88)
Your panel is scientifically curated to focus on the essential drivers of your long-term health
If youre worried about rare or severe semaglutide side effects like pancreatitis, its probably worth mentioning to your physician if: You have a history of pancreatitis Youve had gallstones You drink alcohol regularly/heavily You suffer from hypertriglyceridemia Youre currently taking medication, which also carries a risk of pancreatitis Checking one or more of these boxes does not automatically mean youll develop pancreatitis from your GLP-1 medication
Backed by experts
Its a phenomenon that gave rise to #Ozempicbabies on social media
Vet the vial, not your own decision Here is where skepticism actually belongs, and it is not aimed at you
